Roche Diagnostics has announced that the Elecsys anti-hepatitis C virus (HCV) assay has received regulatory approval in Europe for the E170 analyser for modular analytics and the e601 module for the Cobas 6000 platform. The Elecsys anti-HCV assay is already available on the Elecsys 2010 and the Cobas e411 instruments.
Stago’s objective is to improve the health of as many people as possible by offering powerful biotechnology solutions for blood-based diagnostics.
We take a lean, confidence-building approach to digital connectivity – from our latest Coag.One middleware to our cyber-secure Connect.One capability for enhanced engineering and remote...
Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024
Liverpool Arena and Convention Centre
31 March - 3 April, 2025
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
ICC Ghent, Belgium
24-26 June, 2025
ACV, Vienna, Austria
6 -10 September, 2025
